Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
We have previously shown that users of oral contraceptive (OC) medications exhibit increased plasma levels of angiotensin II (Ang II) with only modest hemodynamic consequences, suggesting estrogen-mediated Ang II type 1 (AT(1)) receptor downregulation. Accordingly, in 10 women who were OC users and 10 women who, as OC nonusers, served as controls, all mean age 26 +/- 1 yr, we examined the renal and peripheral hemodynamic response to graded Ang II infusion, plasma and urine cyclic guanosine monophosphate (cGMP) levels as a surrogate marker for AT(1) and/or AT(2) receptor-mediated activation of the nitric oxide pathway, and AT(1) receptor expression in skin biopsies. The OC nonusers were studied during the follicular and luteal phases of the menstrual cycle, whereas OC users were studied once during the 21-d medication phase. Subjects ingested a controlled sodium diet for 7 d before each study. Renal hemodynamic function was assessed using standard inulin and p-aminohippurate clearance techniques. AT(1) receptor mRNA levels in skin biopsy samples were assessed using a real-time PCR protocol. In response to graded Ang II infusion, OC users exhibited renal and peripheral hemodynamic responses that were augmented compared with those of OC nonusers, in conjunction with evidence of increased tissue AT(1) receptor expression. Plasma cGMP levels and 24-h urinary cGMP excretion did not differ. These data suggest that, contrary to our original hypothesis, OC use does not appear to be associated with AT(1) receptor downregulation. The factor protecting OC users from the hemodynamic impact of increased Ang II levels remains elusive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen Modulates AT 1 Receptor Gene Expression In Vitro and In Vivo
Nickenig, G., Bäumer, A. T., Grohè, C., Kahlert, S., Strehlow, K., Rosenkranz, S., Stäblein, A., Beckers, F., Smits, J. F. M., Daemen, M. J. A. P., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2197 · Cited by 409 · cited 1×
“Estradiol causes the downregulation of AT1 receptor mRNA and density in vascular smooth muscle cells, and estrogen deficiency leads to the upregulation of vascular AT1 receptor expression accompanied by an increased effect of Ang II on tension in isolated rat aortic rings (40).”
BackgroundEstrogen regulation of angiotensin-converting enzyme mRNA
Gallagher, P. E., Li, P., Lenhart, J. R., Chappell, M. C., & Brosnihan, K. B. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.323 · Cited by 290
Impact of gender on the renal response to angiotensin II
Miller, J. A., Anacta, L. A., & Cattran, D. C. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00260.x · Cited by 255
Self-citationBrosnihan, K. B., Li, P., Ganten, D., & Ferrario, C. M. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.6.r1908 · Cited by 156
Sealey, J. E., Itskovitz-Eldor, J., Rubattu, S., James, G. D., August, P., Thaler, I., Levron, J., & Laragh, J. H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027239 · Cited by 115
Regulation of angiotensinogen gene expression by estrogen
Gordon, M. S., Chin, W. W., & Shupnik, M. A. (1992) · Journal of Hypertension · doi:10.1097/00004872-199204000-00007 · Cited by 106
Effect of oral contraceptives on the renin angiotensin system and renal function
Kang, A. K., Duncan, J. A., Cattran, D. C., Floras, J. S., Lai, V., Scholey, J. W., & Miller, J. A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.3.r807 · Cited by 103
Self-citationEffects of chronic hormone replacement on the renin–angiotensin system in cynomolgus monkeys
Brosnihan, K. B., Weddle, D., Anthony, M. S., Heise, C., Li, P., & Ferrario, C. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715070-00003 · Cited by 70
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Nicholl, D. D. M., Hanly, P. J., Poulin, M. J., Handley, G. B., Hemmelgarn, B. R., Sola, D. Y., & Ahmed, S. B. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0526oc · Cited by 119
Self-citationThe effect of oral contraceptives on the nitric oxide system and renal function
Cherney, D. Z. I., Scholey, J. W., Cattran, D. C., Kang, A. K., Zimpelmann, J., Kennedy, C., Lai, V., Burns, K. D., & Miller, J. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00351.2007 · Cited by 33
Self-citationDavis, G. C., Gibson, K. J., Casley, D., & Brown, M. A. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001310 · Cited by 13
Metadata
- Authors
- Ahmed, S. B., Kang, A. K., Burns, K. D., Kennedy, C. R. J., Lai, V., Cattran, D. C., Scholey, J. W., & Miller, J. A.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2004-03
- Volume
- 15
- Issue
- 3
- Pages
- 780-786
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2105249497
- Cited by
- 54
- References
- 8
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion. https://app.cochat.ai/papers/10.1097/01.asn.0000114555.16297.5a
- The paper
- Ahmed, S. B., Kang, A. K., Burns, K. D., Kennedy, C. R. J., Lai, V., Cattran, D. C., Scholey, J. W., & Miller, J. A. (2004). Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000114555.16297.5a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.